- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05060978
Evaluation of the Effect of Two Online Interventions -Watch Your Weight During the Holidays Program and the Relative 5:2 Fasting- for the Prevention of Body Weight Gain at 8 Weeks in Mexican Adults in the Covid-19 Pandemic
May 12, 2023 updated by: Rolando Giovanni Díaz Zavala, Universidad de Sonora
Evaluation of the Effect of Two Online Interventions -Watch Your Weight During the Holidays Program and the Relative 5:2 Fasting- for the Prevention of Body Weight Gain at 8 Weeks in Mexican Adults in the Covid-19 Pandemic: A Pilot Three Arm Parallel-Group Randomized Controlled Trial
Introduction.
Obesity is the main risk factor for the development of chronic degenerative diseases in Mexico and other countries around the world.
Due to the difficulty of treating obesity, it is necessary to change the curative paradigm for a preventive one.
A review showed that holiday periods during the year are critical points for weight gain.
The holiday season is the festive period with the greatest impact on adults' body weight.
Observational studies have shown that more than 50% of the annual weight is gained during this period.
However, few preventive interventions in the festive period have been carried out globally.
Additionally, the COVID-19 pandemic seems to be negatively affecting diet, physical activity and body weight.
So preventive interventions are needed, especially those that can be implemented in an online format.
The purpose of the study is to evaluate the effect of two online interventions -Watch your Weight during the Holidays Program and the Relative 5:2 Fasting - on the prevention of body weight gain from baseline to 8 weeks in comparison with a control group in Mexican adults during the COVID-19 pandemic.
Methodology: This is a Pilot Randomized Controlled Trial (RCT).
The primary outcome is the change in body weight from baseline to 8 weeks.
Secondary outcomes are the percentage of retention / desertion of the participants, adherence to interventions, participant satisfaction scale, changes in other obesity parameters, biochemical, physical, and quality of life variables from baseline to 8 weeks.
Obesity and quality of life parameters from baseline to 52 weeks are also secondary outcomes.
The statistical analysis of the primary and secondary variables will be conducted, according to their distribution, by intention to treat and, secondarily, by completer´s analysis.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sonora
-
Hermosillo, Sonora, Mexico, 83000
- Centro de Promoción de Salud Nutricional (CPSN)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Mexican adult participants (≥20 and ≤60 years)
- Residents of the city of Hermosillo, Sonora
- Body Mass Index ≥ 23 kg/m2 and ≤ 40 kg/m2
- Availability and motivation to attend the intervention program
- Committed to not undertake any other intervention in place of, or in combination with, the one assigned in the study during the 8 weeks of the intervention
Exclusion Criteria:
- Diagnosed medical conditions that constitute a contraindication for intervention such as: diabetes, hypertension, diseases with an effect on body weight (for example: liver failure; cancer in treatment or in advanced stage; history of COVID-19 that required hospitalization, supplemental oxygen or has left sequelae that contraindicates the intervention; psychiatric conditions; eating disorders, etc.).
- Use of drugs or substances with an effect on weight, for example, metformin, orlistat, corticosteroids, etc.
- Use of addictive substances such as drugs of abuse
- Previous bariatric surgery.
- Being a participant in another intervention or treatment for the management of obesity.
- Weight loss > 5% of total body weight in the last 4 months.
- Having plans to become pregnant within the study period, currently pregnant or breastfeeding.
- Another family member has agreed to participate in the study.
- Illiteracy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Control Group
|
Participants in this group will receive online information and a PDF file brochure during an individual video call session at the beginning of the 8-week period.
This information will be about leading a healthy eating based on the norm for health promotion and education for healthy eating in Mexico (NOM-043-SSA2-2012).
|
Active Comparator: Watch your Weight During the Holidays Program
|
Participants in this group will have two video call individual sessions and one video call group session.
This intervention will include self-monitoring strategies (self-weighing, diet monitoring and physical activity), and nutrition counseling and education.
In addition, participants in this group will receive a weighing scale to achieve self-monitoring of body weight from the beginning of the study intervention until the end of the 52-weeks follow-up.
|
Active Comparator: Relative 5:2 Fasting
|
Participants in this group will will have two video call individual sessions and one video call group session.
This intervention will receive eating recommendations to follow a 5:2 intermittent fasting.
They will be given low-calorie menus of 550 kcal and 660 kcal, for women and men respectively, which the participants in this group will apply on fasting days.
The fasting will be held twice a week and on the remaining five days, the participants will not have any type of caloric restriction (it will be ad libitum).
They will only have the general recommendation to adhere to a healthy dietary pattern.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes in body weight
Time Frame: Baseline to 8 weeks
|
Baseline to 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in body weight
Time Frame: Baseline and 52 weeks
|
Baseline and 52 weeks
|
|
Changes in kilograms of body fat
Time Frame: Baseline, 8 weeks and 52 weeks
|
Baseline, 8 weeks and 52 weeks
|
|
Changes in waist circumference
Time Frame: Baseline, 8 weeks and 52 weeks
|
Baseline, 8 weeks and 52 weeks
|
|
Changes in systolic blood pressure
Time Frame: Baseline, 8 weeks and 52 weeks
|
Baseline, 8 weeks and 52 weeks
|
|
Changes in diastolic blood pressure
Time Frame: Baseline, 8 weeks and 52 weeks
|
Baseline, 8 weeks and 52 weeks
|
|
Changes in perception of health related quality of life
Time Frame: Baseline, 8 weeks and 52 weeks
|
The SF-36 Health Survey evaluates aspects of the quality of life in adult populations (over 16 years of age).
The result of its application is the generation of eight concepts or scales of health, result of the average of the sum of the questions contained in the questionnaire for each concept.
These concepts are: physical function, physical role, corporal pain, general health, vitality, social function, emotional role and mental health.
The SF-36 is a self-applied instrument and contains 36 questions.
For each scale, the answers to each question are coded and recoded (10 questions), and the results are interpreted on a scale of 0 to 100, lower results indicate poorer health and greater result better health.
|
Baseline, 8 weeks and 52 weeks
|
Retention / desertion
Time Frame: 8 weeks and 52 weeks
|
The retention percentage will be obtained by dividing the number of people that finished the intervention the number that started the intervention, multiplied by 100.
The dropout percentage will be obtained by the difference in the number of subjects who started and finished the intervention, multiplied by 100.
|
8 weeks and 52 weeks
|
Adherence to intervention
Time Frame: 8 weeks and 52 weeks
|
Adherence to the intervention will be calculated as the percentage of study measurement appointments and group sessions attended by each participant.
Another way to measure adherence to interventions will be with a numerical scale of self-evaluation from 1 to 5, where 1 is the lowest score and 5 is the highest, to indicate how adherent they were to the meal plans.
|
8 weeks and 52 weeks
|
Participant satisfaction scale
Time Frame: 8 weeks and 52 weeks
|
Satisfaction of the participants in each of the intervention groups will be measured online using a scale from 1 to 5, where 1 is the lowest rating and 5 is the highest.
A higher score means a higher satisfaction with the intervention recieved.
|
8 weeks and 52 weeks
|
Changes in fasting glucose
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
|
Changes in total cholesterol
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
|
Changes in LDL cholesterol
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
|
Changes in HDL cholesterol
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
|
Changes in triglycerides
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Rolando G Díaz Zavala, Ph.D., Universidad de Sonora
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 10, 2021
Primary Completion (Actual)
February 11, 2022
Study Completion (Actual)
February 11, 2022
Study Registration Dates
First Submitted
September 27, 2021
First Submitted That Met QC Criteria
September 27, 2021
First Posted (Actual)
September 29, 2021
Study Record Updates
Last Update Posted (Actual)
May 16, 2023
Last Update Submitted That Met QC Criteria
May 12, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- USO313007128
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Watch your Weight During the Holidays Program
-
Rolando Giovanni Díaz ZavalaRecruitingObesity | Overweight | Weight GainMexico
-
Dokuz Eylul UniversityCompletedPain | Anxiety State | Fear | Child, OnlyTurkey
-
University of Illinois at Urbana-ChampaignRecruitingObesity | Weight Loss | Food CravingsUnited States
-
Novindiet ClinicTehran University of Medical Sciences; University of NottinghamCompletedOverweight | Type 2 Diabetes | ObeseIran, Islamic Republic of
-
Janssen Scientific Affairs, LLCApple Inc.Active, not recruitingAtrial FibrillationUnited States
-
University of South CarolinaCompletedOverweight | Body Weight ChangesUnited States
-
University of Colorado, DenverUnited States Department of Agriculture (USDA)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Indiana UniversityCompletedMetastatic Breast CancerUnited States
-
Umm Al-Qura UniversityCompletedDiabetic PolyneuropathySaudi Arabia
-
City of Hope Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Icahn...Recruiting